FDA panel votes against Lilly-Boehringer Ingelheim’s diabetes drug Reuters Nov 14, 2019 The drug, empagliflozin, was approved in 2014 in doses of 10 mg and 20 mg to help lower blood sugar levels in patients with type 2…
